14 April 2016 - Major changes to the UK pharma market have been delayed because of the EU referendum on 23 June.

Civil servants must observe a period of 'purdah' in the weeks before a general election or referendum, which restricts government activity to avoid unfairly influencing public opinion.

This has hit two major consultations for the pharma industry – the Accelerated Access Review (AAR) and proposed changes to the medicines pricing system known as the Statutory Scheme.

The AAR is the brainchild of life sciences minister George Freeman, who wants it to re-shape the UK market and the NHS around encouraging medical innovation, and remove some of the blocks and bottlenecks which plague the current system.

For more details, go to: http://www.pharmaphorum.com/news/uk-pharma-reforms-delayed-until-after-eu-referendum